Wickliffe Pharmaceutical, Inc.
Form 483 issued May 22, 2014 · Lexington, Kentucky
- Inspection
- Apr 29 – May 22, 2014
- Investigator
- Kathleen Dt Culver
- Observations
- 2
- Pages
- 1
- FEI number
- 3002992930
In short: On May 22, 2014, FDA issued a Form 483 with 2 observations to Wickliffe Pharmaceutical, Inc. in Lexington, Kentucky (FEI 3002992930) after an inspection that ran Apr 29 – May 22, 2014. The investigator was Kathleen Dt Culver. Most observations concern laboratory controls.
At a glance
2 of 2 observations on this 483 concern laboratory controls.
What FDA observed
Preview: the opening words of each observation- 01
Observation 1: scanned text, readable in the full document.
- 02
FDA laboratory analysis of lot 25-03 -2014@25 (BUD 9/2 1/2014) oftoltrazuril and pyrimethamine oral paste labeled…
This inspection in context
Kathleen Dt Culver
2 documents · 2014–2015
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Kentucky.
The firmWickliffe Pharmaceutical, Inc. history
All 8 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at Wickliffe Pharmaceutical, Inc.?
FDA listed 2 observations on this Form 483, mostly about laboratory controls. The opening words of each observation are shown on this page.
Who inspected Wickliffe Pharmaceutical, Inc.?
Kathleen Dt Culver is named on this Form 483, for the inspection of Apr 29 – May 22, 2014. Each investigator has a profile showing what they cite most.
When was Wickliffe Pharmaceutical, Inc. inspected by FDA?
The inspection ran Apr 29 – May 22, 2014, and the Form 483 is dated May 22, 2014.
How do I get the full Form 483 for Wickliffe Pharmaceutical, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.